Earnings Call Transcript Summaries

AI-generated key takeaways from quarterly earnings calls of Indian listed companies. Management commentary on revenue, margins, guidance, and outlook — summarised within hours of filing.

🔔 Add stocks to your watchlist — get instant Telegram alerts when they file results Start free trial →
462 transcripts
Protean eGov Technologies Limited Q1FY27
07 Aug 2026
  • Normalized EBITDA margin ~17.2% excluding investments; investments expected to boost future revenue and margins
  • Tax Services stable despite 12% PAN issuance decline; market share up to 62%
  • CRA Services onboarded 3.9 mn subscribers; 97% market share in pension schemes
Read full summary →
Central Depository Services (India) Limited Q1FY27
07 Aug 2026
  • Q1 FY27 standalone income INR327 Cr; net profit INR144 Cr; consolidated income INR341 Cr; net profit INR118 Cr
  • No forward guidance given; ISIN issuance capability in progress
  • Opened 58 lakh new demat accounts; total 18.59 crore accounts; ~80% market share
Read full summary →
Computer Age Management Services Limited Q1FY27
07 Aug 2026
  • Capex: INR75 Cr on-prem expected in FY27; INR290 Cr total re-arch project capex with 10-year amortization
  • Yield compression largely in base; residual impact minimal; expect 2.5-3% annual yield decline
  • Q1 FY27 EBITDA grew 18% y-y to INR183 Cr; PAT up 17%; EBITDA margin expanded 270 bps to 46.4%
Read full summary →
DLF Limited Q1FY27
07 Aug 2026
  • Privana next phase launch expected early next year; no plotted development planned
  • Q1 FY27 collections at INR 2,406 Cr; operating cash flow over INR 1,300 Cr; net cash INR 15,200 Cr
  • FY28 expected as inflection point with large projects like Arbour contributing to P&L
Read full summary →
PNB Housing Finance Limited Q1FY27
07 Aug 2026
  • Margin and yield expected to improve from H2 FY27; cost of borrowing bottomed out
  • Q1 FY27 disbursements grew 18% Y-o-Y to INR 5,882 Cr; 56% growth on cheque handover basis
  • Growth guidance maintained: 18-20% overall book, 50-60% Affordable segment growth for FY27
Read full summary →
ABB India Limited Q1FY27
07 Aug 2026
  • Macro uncertainties and commodity prices remain headwinds; mid-teens EBITDA margin guidance not yet comfortable
  • Price hikes taken twice in quarter to offset commodity inflation; lag in price pass-through expected
  • Capex of USD75-80 million planned to maintain 15% capacity headroom for 15-20% sales growth
Read full summary →
Mtar Technologies Limited Q1FY27
06 Aug 2026
  • Capex INR500 Cr planned over FY27-FY28; INR35 Cr spent in Q1
  • Q1 FY27 revenue INR360.7 Cr +130% y-y; EBITDA INR85.1 Cr margin 23.6%
  • FY27 revenue growth guidance 80% with EBITDA margin ~24%, confident to exceed
Read full summary →
Hyundai Motor India Ltd Q1FY27
06 Aug 2026
  • Margin impacted by production disruption, US-Iran conflict, commodity costs; EBITDA guidance 11-14% for FY27
  • New ICE mid-SUV launch in festive season; two new models expected to boost H2 growth and market share
  • Q1 FY27 total sales 178,082 vehicles, -1.3% y-y; domestic sales up 5.4%, exports down 19.6%
Read full summary →
Indian Railway Finance Corporation Limited Q1FY27
06 Aug 2026
  • IRFC aims to surpass last year's disbursement of INR35,000 Cr in FY27, targeting INR5 lakh Cr AUM by year-end
  • NIM expected to grow ~10 bps annually, targeting 2% by FY30
  • Q1 slower disbursement (~INR2,000 Cr), pick-up expected in Q2-Q4
Read full summary →
Escorts Kubota Ltd Q1FY27
06 Aug 2026
  • Construction equipment revenue INR419.6 Cr +39.2% y-y; industry growth 12-15% expected FY27; market share gains ongoing
  • Commodity inflation impacted margins; 5% cost increase in Q1 plus 1.5-2% expected in Q2; price hikes taken and planned
  • Capex guidance INR850-900 Cr FY27 including greenfield land acquisition; normal capex INR350-400 Cr
Read full summary →
Leela Palaces Hotels & Resorts Limited Q1FY27
06 Aug 2026
  • Q1 FY27 operating revenue grew 28% y-y to INR3.52bn; operating EBITDA rose 41% y-y to INR1.43bn with 41% margin
  • FY27 guidance: double-digit RevPAR growth, mid-to-high teens EBITDA growth
  • Tadoba resort project signed for INR1.2bn, 30 keys, targeted CY30 completion
Read full summary →
Sun Pharmaceutical Industries Limited Q1FY27
06 Aug 2026
  • Q1 FY27 consolidated sales grew 10.1% y-y to INR151,836 million; EBITDA margin 28.9%
  • R&D spend at 5.4% of sales; 30% on innovative medicines; Organon acquisition on track for Q4 FY27
  • Management expects high single-digit revenue growth for FY27; tax rate around 27.8%
Read full summary →
Tata Steel Ltd Q1FY27
06 Aug 2026
  • Board approved 4.8 MTPA NINL expansion with Rs 33,873 Cr capex; commissioning expected in 48 months
  • Multiple analyst queries on European market pricing and regulatory challenges; management expects phased price recovery and ongoing regulatory engagement
  • Tata Steel reported resilient 1QFY27 with consolidated revenue Rs 60,794 Cr and EBITDA Rs 9,370 Cr, 15% margin
Read full summary →
Thermax Limited Q1FY27
06 Aug 2026
  • INR 300 crore shipment delay impacted Industrial Products profitability; commodity price rise added INR 10 crore cost
  • Focus on exiting low-margin government projects; aiming for 10%+ EBITDA margin in Industrial Infra
  • Q2-Q4 expected to show significant profitability improvement over last year
Read full summary →
Divi's Laboratories Limited Q1FY27
06 Aug 2026
  • Ongoing capex projects nearing completion; validation batches progressing
  • Gross margin approx. 68% in Q1; full-year margin expected near last year's level
  • Q1 FY27 consolidated total income ₹3,144 Cr (+24% y-y); PAT ₹902 Cr (+65% y-y)
Read full summary →
Exide Industries Ltd Q1FY27
06 Aug 2026
  • Lithium-ion plant utilization target 25-30% in FY27; capacity 6 GWh Phase 1, potential expansion to 12 GWh
  • Lead acid battery capex INR500 Cr annually for capacity and tech upgrades; focus on bottlenecks and brownfield expansions
  • Standalone Q1 FY27 revenue grew 17.6% y-y; EBITDA INR655 Cr +19.5% y-y; margin 12.4%, +20 bps y-y
Read full summary →
The Karnataka Bank Limited Q1FY27
06 Aug 2026
  • Q1 FY27 aggregate business at INR1,97,007 Cr, +3% Q-o-Q, +11% Y-o-Y
  • ROE 12.48%, ROA 1.29% in Q1 FY27; aiming 1.35-1.40% ROA for FY27
  • Branch expansion planned: 31-32 new branches in FY27
Read full summary →
Clean Science and Technology Limited Q1FY27
06 Aug 2026
  • Supply chain disruptions impacted volumes in Q1; improvements expected in Q2 but raw material price volatility remains
  • EBITDA margins expected to improve with higher grade HALS sales and operational efficiencies
  • Q1 FY27 consolidated revenue grew 10% y-y to INR 264 Cr; standalone revenue down 6% y-y but up 5% q-o-q to INR 203 Cr
Read full summary →
Cartrade Tech Limited Q1FY27
05 Aug 2026
  • Q1 margins impacted by wage increments; expect margin expansion in Q2-Q4
  • Standalone consumer business revenue stable q-q, up 18% y-y; EBITDA margin 33%
  • Elite Buyer program crossed 100,000 monthly users; monetization to expand with mandatory paid plans for business buyers
Read full summary →
Dixon Technologies (India) Limited Q1FY27
05 Aug 2026
  • Mobile & EMS revenue INR14,179 Cr; operating profit INR373 Cr; Q2 smartphone volume growth guidance 20-25% q-o-q
  • Q1 FY27 revenue INR15,557 Cr; EBITDA INR472 Cr; PAT INR218 Cr excluding fair value gains
  • Telecom revenue INR2,100 Cr; expected growth to INR6,700-7,000 Cr in FY27; operating margin ~5.1%
Read full summary →
Nuvama Wealth Management Limited Q1FY27
05 Aug 2026
  • Q1 FY27 quarterly profit crossed INR300 crores, surpassing FY22 full-year profit
  • Asset management losses expected INR35-40 crores in FY27; breakeven expected post Q4
  • Offshore business breakeven in Dubai; Singapore breakeven expected by year-end
Read full summary →
Glenmark Pharmaceuticals Limited Q1FY27
05 Aug 2026
  • Gross margin impacted by geopolitical cost pressures; full-year margin guidance maintained at 21-22%
  • India business growth guidance 12-15% with volume-led growth and new product launches
  • Key priorities: US respiratory launches in H2 FY27, oncology launches Aumolertinib, Trastuzumab Rezetecan, envafolimab
Read full summary →
Swiggy Limited Q1FY27
05 Aug 2026
  • Swiggy plans growth focus in quick commerce with contribution margin (CM) near zero to -100 bps in FY27
  • Food delivery growth guided at 18-20% YoY with under-penetrated market opportunity
  • Take rate improvement driven by brand monetization, advertising, and user fees; sustainable per management
Read full summary →
Balkrishna Industries Limited Q1FY27
05 Aug 2026
  • Price hike of ~5% taken in Q1; raw material cost expected to impact margin by ~2% in Q2
  • Q1 FY27 OHT segment volume grew 16% y-y to 93,770 MT; standalone revenue rose 24% y-y to INR3,409 Cr
  • EBITDA margin at 20.61%, impacted by raw material inflation and higher India volume share
Read full summary →
Vishnu Chemicals Limited Q1FY27
05 Aug 2026
  • Capex of INR200-250 Cr planned for FY27, mainly for DMSO, chrome oxide green expansion, barium backward integration
  • Logistics cost rose to 9-10% in Q1, expected to rise to 20% in Q2; company working to pass on costs
  • Barium segment EBITDA margin impacted by one-off INR8 Cr expense; sustainable margin expected at 25%
Read full summary →
APL Apollo Tubes Limited Q1FY27
05 Aug 2026
  • Employee cost increase due to annual increments and low production; expected to normalize with volume recovery.
  • July volumes rose 20% MoM; full-year EBITDA growth guidance maintained at 20% with 15-20% volume growth.
  • EBITDA per ton expected to improve gradually to INR6,000 over 2-3 years with capacity ramp-up.
Read full summary →
BAJAJ FINSERV LTD. Q1FY27
05 Aug 2026
  • Motor insurance pricing soft; tactical risk selection ongoing; combined ratio better than market by 16-18%
  • Consolidated total income grew 19% to INR 42,037 Cr; PAT up 18% to INR 6,297 Cr in Q1 FY27
  • Emerging businesses: Bajaj Finserv Direct breakeven expected Q3/Q4 FY27; Health breakeven FY28; Asset Mgmt AUM +26%
Read full summary →
KPIT Technologies Limited Q1FY27
04 Aug 2026
  • Q1 FY27 revenue nearly flat y-y with 0.1% constant currency growth, USD revenue down 0.6%, Q-o-Q decline 3.6%
  • H2 FY27 expected to see growth recovery, with Q4 driving return to growth and profitability
  • Medium-term margin aspiration of 22-24% by FY29 remains, driven by product/solution revenue growth and outcome-based models
Read full summary →
Aequs Limited Q1FY27
04 Aug 2026
  • Consumer segment EBITDA loss narrowed by INR112 million sequentially; on track for Q4 FY27 breakeven
  • Consumer utilization at 22%, expected to reach 40-50% by Q4 FY27
  • ROCE target steady at 18-22% for both segments; PAT breakeven expected by H1 FY28 for consumer
Read full summary →
⚡ What you get within minutes of every filing
ISA
Indian Stock Alerts BOT
🚨 RELIANCE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add your stocks — never miss an earnings alert or concall summary again.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime
About these summaries. Earnings call transcripts are filed on BSE/NSE after quarterly results. Our AI reads the full transcript and extracts key takeaways: outlook, demand drivers, margin commentary, risk factors, and capital allocation plans. Summaries are generated within hours of filing. Browse all filings → · Company directory →